Carcinoid vs Neuroendocrine (20th century vs 21st century) - Read more on Ronny Allan - Living with #NeuroendocrineCancer buff.ly/2yoxFOa

Let's move into the 21st Century with #NeuroendocrineCancer awareness buff.ly/2n3cngH

#NeuroendocrineCancer - not as rare as you think #LetsTalkAboutNETs accurately - also #LetsTalkAboutPeople rather than animals buff.ly/2N5x865

If first and second line doctors were told it isn’t rare, they might look for it more, just saying. It's now the 7th most common cancer in Australia and the 10th in UK. #LetsTalkAboutNETs accurately #WorldNeuroendocrineCancerDay #NeuroendocrineCancer buff.ly/2MvIUYd

Opinion: Neuroendocrine Cancer Awareness – let’s move into the 21st century buff.ly/3XfU4Y7

Histamine – The NET Effect buff.ly/42z0ySr

Let’s be clear about Neuroendocrine Tumours – it’s a cancer! - Ronny Allan - Living with Neuroendocrine Cancer buff.ly/3T8F0Zo

NET or NOT - Ronny Allan - Living with Neuroendocrine Cancer buff.ly/4dHoPda

FDA grants ODD to Abdera’s neuroendocrine carcinoma treatment pharmaceutical-technology.com/news/fda-odd-a… via Pharma Technology Focus

Currently trending on RonnyAllan.NET buff.ly/3sDJB71

Lanreotide: Ipsen injection devices vs generic injection devices buff.ly/3XbXl94

Weekly round-up 2nd – 8th September 2024 ronnyallan.net/2024/09/09/wee…

Currently trending on RonnyAllan.NET buff.ly/3sDJB71

Lanreotide: Ipsen injection devices vs generic injection devices buff.ly/3XbXl94

Weekly round-up 2nd – 8th September 2024 - Ronny Allan - Living with Neuroendocrine Cancer buff.ly/4e4S4Y7

Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis #NeuroendocrineCancer buff.ly/3XGkMZA

New type of small cell lung cancer identified | ScienceDaily #NeuroendocrineCancer buff.ly/47r75kl

Weekly round-up 2nd – 8th September 2024 - Ronny Allan - Living with Neuroendocrine Cancer buff.ly/4e4S4Y7

The 50 shades of Neuroendocrine Neoplasms buff.ly/4eQr4ML